$AWR
AMERICAN STATES WATER CO Stock $awr

$awr Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000162828023037070 Filed on November 06, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$125.2M	$151.7M
YoY Change	-0.15%	12.38%
Cost Of Revenue	$24.03M	$29.90M
YoY Change	-8.84%	11.34%
Gross Profit	$101.2M	$121.8M
YoY Change	2.16%	12.64%
Gross Profit Margin	80.81%	80.29%
Selling, General & Admin	$22.24M	$21.00M
YoY Change	5.11%	-2.75%
% of Gross Profit	21.99%	17.24%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$10.95M	$10.18M
YoY Change	-0.5%	0.66%
% of Gross Profit	10.83%	8.36%
Operating Expenses	$66.38M	$70.00M
YoY Change	-7.13%	3.26%
Operating Profit	$34.78M	$51.75M
YoY Change	26.29%	28.29%
Interest Expense	-$9.238M	$11.69M
YoY Change	35.02%	59.47%
% of Operating Profit	-26.56%	22.59%
Other Income/Expense, Net	$2.883M	-$10.64M
YoY Change	15.55%	68.18%
Pretax Income	$28.52M	$41.11M
YoY Change	22.59%	20.87%
Income Tax	$8.096M	$9.547M
% Of Pretax Income	28.38%	23.22%
Net Earnings	$20.34M	$31.57M
YoY Change	9.48%	23.04%
Net Earnings / Revenue	16.25%	20.81%
Basic Earnings Per Share		$0.85
Diluted Earnings Per Share	$0.55	$0.85
COMMON SHARES
Basic Shares Outstanding	36.98M shares	36.98M shares
Diluted Shares Outstanding		37.07M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.07M	$10.10M
YoY Change	-21.13%	2.78%
Cash & Equivalents	$14.07M	$8.604M
Short-Term Investments	$0.00	$1.500M
Other Short-Term Assets	$74.43M	$63.10M
YoY Change	85.41%	38.67%
Inventory	$17.57M	$16.20M
Prepaid Expenses
Receivables	$34.25M	$32.60M
Other Receivables	$52.00K	$0.00
Total Short-Term Assets	$206.0M	$191.7M
YoY Change	36.14%	38.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.892B	$1.850B
YoY Change	7.9%	7.7%
Goodwill	$1.116M	$1.116M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$18.76M	$15.01M
YoY Change	38.62%	-2.15%
Total Long-Term Assets	$2.040B	$2.014B
YoY Change	8.34%	9.21%
TOTAL ASSETS
Total Short-Term Assets	$206.0M	$191.7M
Total Long-Term Assets	$2.040B	$2.014B
Total Assets	$2.246B	$2.205B
YoY Change	10.41%	11.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$68.71M	$71.83M
YoY Change	-19.03%	2.64%
Accrued Expenses	$39.86M	$43.00M
YoY Change	6.41%	494.42%
Deferred Revenue	$1.352M	$596.0K
YoY Change	49.72%	-52.43%
Short-Term Debt	$42.00M	$37.00M
YoY Change	-83.56%	-84.49%
Long-Term Debt Due	$353.0K	$400.0K
YoY Change	-11.53%	0.25%
Total Short-Term Liabilities	$166.6M	$195.0M
YoY Change	-57.98%	-47.74%
LONG-TERM LIABILITIES
Long-Term Debt	$575.6M	$575.5M
YoY Change	28.89%	28.79%
Other Long-Term Liabilities	$14.41M	$14.72M
YoY Change	0.06%	3.89%
Total Long-Term Liabilities	$727.8M	$590.2M
YoY Change	51.08%	28.03%
TOTAL LIABILITIES
Total Short-Term Liabilities	$166.6M	$195.0M
Total Long-Term Liabilities	$727.8M	$590.2M
Total Liabilities	$894.5M	$785.2M
YoY Change	1.84%	-5.87%
SHAREHOLDERS EQUITY
Retained Earnings	$512.9M	$508.5M
YoY Change	14.14%	14.13%
Common Stock	$263.2M	$262.9M
YoY Change	1.16%	1.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$776.1M	$771.3M
YoY Change
Total Liabilities & Shareholders Equity	$2.246B	$2.205B
YoY Change	10.41%	11.23%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	$20.34M	$31.57M
YoY Change	9.48%	23.04%
Depreciation, Depletion And Amortization	$10.95M	$10.18M
YoY Change	-0.5%	0.66%
Cash From Operating Activities	$11.18M	$38.70M
YoY Change	-59.87%	17.17%
INVESTING ACTIVITIES
Capital Expenditures	$52.44M	$47.50M
YoY Change	18.69%	-204.39%
Acquisitions
YoY Change
Other Investing Activities	-$1.224M	$200.0K
YoY Change	3.47%	8.11%
Cash From Investing Activities	-$53.56M	-$47.40M
YoY Change	18.07%	4.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	47.86M	16.20M
YoY Change	125.32%	335.02%
NET CHANGE
Cash From Operating Activities	11.18M	38.70M
Cash From Investing Activities	-53.56M	-47.40M
Cash From Financing Activities	47.86M	16.20M
Net Change In Cash	5.476M	7.500M
YoY Change	46.46%	-187.55%
FREE CASH FLOW
Cash From Operating Activities	$11.18M	$38.70M
Capital Expenditures	$52.44M	$47.50M
Free Cash Flow	-$41.26M	-$8.800M
YoY Change	152.83%	-111.21%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	606000	usd
CY2023Q3	awr	Dividends Equivalent Rights On Share Based Compensation Not Paid In Cash Net Of Tax DividendsEquivalentRightsOnShareBasedCompensationNotPaidInCashNetOfTax	48000	usd
CY2023Q3	us-gaap	Dividends Common Stock DividendsCommonStock	15900000	usd
CY2023Q3	awr	Dividends Equivalent Rights On Share Based Compensation Net Of Tax DividendsEquivalentRightsOnShareBasedCompensationNetOfTax	48000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	771337000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	801000	usd
CY2022Q1	awr	Dividends Equivalent Rights On Share Based Compensation Not Paid In Cash Net Of Tax DividendsEquivalentRightsOnShareBasedCompensationNotPaidInCashNetOfTax	41000	usd
CY2022Q1	us-gaap	Dividends Common Stock DividendsCommonStock	13485000	usd
CY2022Q1	awr	Dividends Equivalent Rights On Share Based Compensation Net Of Tax DividendsEquivalentRightsOnShareBasedCompensationNetOfTax	41000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	687425000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	19951000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	338000	usd
CY2022Q2	awr	Dividends Equivalent Rights On Share Based Compensation Not Paid In Cash Net Of Tax DividendsEquivalentRightsOnShareBasedCompensationNotPaidInCashNetOfTax	34000	usd
CY2022Q2	us-gaap	Dividends Common Stock DividendsCommonStock	13489000	usd
CY2022Q2	awr	Dividends Equivalent Rights On Share Based Compensation Net Of Tax DividendsEquivalentRightsOnShareBasedCompensationNetOfTax	34000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	694225000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	25654000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	315000	usd
CY2022Q3	awr	Dividends Equivalent Rights On Share Based Compensation Not Paid In Cash Net Of Tax DividendsEquivalentRightsOnShareBasedCompensationNotPaidInCashNetOfTax	40000	usd
CY2022Q3	us-gaap	Dividends Common Stock DividendsCommonStock	14690000	usd
CY2022Q3	awr	Dividends Equivalent Rights On Share Based Compensation Net Of Tax DividendsEquivalentRightsOnShareBasedCompensationNetOfTax	40000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	705504000	usd
	us-gaap	Net Income Loss NetIncomeLoss	104493000	usd
	us-gaap	Net Income Loss NetIncomeLoss	59767000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	32327000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	30688000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1238000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	833000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	919000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1098000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3095000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2439000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	2084000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-6445000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	41000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-263000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7632000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1760000	usd
	awr	Increase Decrease In Unbilled Contracts Receivables IncreaseDecreaseInUnbilledContractsReceivables	2983000	usd
	awr	Increase Decrease In Unbilled Contracts Receivables IncreaseDecreaseInUnbilledContractsReceivables	-4393000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	2540000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-3179000	usd
	awr	Increase Decrease Receivable From Government IncreaseDecreaseReceivableFromGovernment	10588000	usd
	awr	Increase Decrease Receivable From Government IncreaseDecreaseReceivableFromGovernment	-5333000	usd
	us-gaap	Increase Decrease In Materials And Supplies IncreaseDecreaseInMaterialsAndSupplies	1595000	usd
	us-gaap	Increase Decrease In Materials And Supplies IncreaseDecreaseInMaterialsAndSupplies	1281000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-403000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-520000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-974000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	3993000	usd
	us-gaap	Increase Decrease In Regulatory Assets And Liabilities IncreaseDecreaseInRegulatoryAssetsAndLiabilities	86070000	usd
	us-gaap	Increase Decrease In Regulatory Assets And Liabilities IncreaseDecreaseInRegulatoryAssetsAndLiabilities	14065000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-8108000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-575000	usd
	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	30621000	usd
	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	947000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-307000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	996000	usd
	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	48000	usd
	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-3070000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	4348000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-28000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	56518000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	89933000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	136131000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	122056000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-952000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-321000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-135179000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-121735000	usd
	us-gaap	Proceeds From Advances For Construction ProceedsFromAdvancesForConstruction	7205000	usd
	us-gaap	Proceeds From Advances For Construction ProceedsFromAdvancesForConstruction	5489000	usd
	us-gaap	Repayments Of Advances For Construction RepaymentsOfAdvancesForConstruction	3839000	usd
	us-gaap	Repayments Of Advances For Construction RepaymentsOfAdvancesForConstruction	3941000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	334000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	377000	usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	129665000	usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	34826000	usd
	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	-5222000	usd
	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	36000000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	45294000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	41664000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	913000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1236000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	81268000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	29097000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2607000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2705000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5997000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4963000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8604000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2258000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	35287000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	37510000	usd
	us-gaap	Contribution Of Property ContributionOfProperty	1555000	usd
	us-gaap	Contribution Of Property ContributionOfProperty	511000	usd
	awr	Number Of Customers NumberOfCustomers	1000000	customer
CY2023Q3	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	10	state
	awr	Number Of Registrants Filing Combined Report NumberOfRegistrantsFilingCombinedReport	2	registrant
CY2023Q2	us-gaap	Debt Instrument Term DebtInstrumentTerm	P5Y
CY2023Q3	awr	Lineof Credit Facility Incremental Expansionof Borrowing Capacity LineofCreditFacilityIncrementalExpansionofBorrowingCapacity	75000000	usd
CY2023Q3	us-gaap	Revenues Revenues	151696000	usd
CY2022Q3	us-gaap	Revenues Revenues	134984000	usd
	us-gaap	Revenues Revenues	470519000	usd
	us-gaap	Revenues Revenues	366161000	usd
CY2023Q3	awr	Regulatory Asset Not Accruing Carrying Costs RegulatoryAssetNotAccruingCarryingCosts	67100000	usd
CY2023Q3	us-gaap	Net Regulatory Assets NetRegulatoryAssets	77667000	usd
CY2022Q4	us-gaap	Net Regulatory Assets NetRegulatoryAssets	-25454000	usd
	awr	Regulatory Asset Amount Billed To Customers As Surcharges RegulatoryAssetAmountBilledToCustomersAsSurcharges	0	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	31565000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	25654000	usd
CY2023Q3	awr	Weighted Average Dividends Common Stock WeightedAverageDividendsCommonStock	15900000	usd
CY2022Q3	awr	Weighted Average Dividends Common Stock WeightedAverageDividendsCommonStock	14690000	usd
	awr	Weighted Average Dividends Common Stock WeightedAverageDividendsCommonStock	45294000	usd
	awr	Weighted Average Dividends Common Stock WeightedAverageDividendsCommonStock	41664000	usd
CY2023Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	46000	usd
CY2022Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	38000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	124000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	104000	usd
CY2023Q3	us-gaap	Undistributed Earnings UndistributedEarnings	15619000	usd
CY2022Q3	us-gaap	Undistributed Earnings UndistributedEarnings	10926000	usd
	us-gaap	Undistributed Earnings UndistributedEarnings	59075000	usd
	us-gaap	Undistributed Earnings UndistributedEarnings	17999000	usd
CY2023Q3	awr	Undistributed Earnings Allocated To Common Stock UndistributedEarningsAllocatedToCommonStock	15574000	usd
CY2022Q3	awr	Undistributed Earnings Allocated To Common Stock UndistributedEarningsAllocatedToCommonStock	10897000	usd
	awr	Undistributed Earnings Allocated To Common Stock UndistributedEarningsAllocatedToCommonStock	58913000	usd
	awr	Undistributed Earnings Allocated To Common Stock UndistributedEarningsAllocatedToCommonStock	17955000	usd
CY2023Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	45000	usd
CY2022Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	29000	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	162000	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	44000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	31474000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36977000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36958000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36974000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36953000	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.85
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.69
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.82
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.61
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	31474000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	25587000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	104207000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	59619000	usd
CY2023Q3	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	45000	usd
CY2022Q3	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	29000	usd
	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	162000	usd
	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	44000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	31519000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	25616000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	104369000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	59663000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36977000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36958000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36974000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36953000	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	94000	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	84000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	90000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	81000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37071000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37042000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37064000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37034000	shares
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.85
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.69
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.82
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.61
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	18351	shares
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	24612	shares
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	913000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1200000	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.4300
CY2022Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.3975
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.2250
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.1275
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19026000	usd
	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	122056000	usd
CY2023Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	3200000	usd
CY2022Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	3400000	usd
CY2023Q3	us-gaap	Revenues Revenues	151696000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	51751000	usd
CY2023Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-9566000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1850471000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10184000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9547000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	47482000	usd
CY2022Q3	us-gaap	Revenues Revenues	134984000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	40340000	usd
CY2022Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-6664000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1718152000	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10117000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8360000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	45504000	usd
	us-gaap	Revenues Revenues	470519000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	161861000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-26108000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1850471000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	31645000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33503000	usd
	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	136131000	usd
	us-gaap	Revenues Revenues	366161000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	99022000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-17859000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1718152000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	30402000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1850471000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1850471000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1718152000	usd
CY2023Q3	awr	Assets Other Than Property Plant And Equipment Net AssetsOtherThanPropertyPlantAndEquipmentNet	354758000	usd
CY2022Q3	awr	Assets Other Than Property Plant And Equipment Net AssetsOtherThanPropertyPlantAndEquipmentNet	264423000	usd
CY2023Q3	us-gaap	Assets Assets	2205229000	usd
CY2022Q3	us-gaap	Assets Assets	1982575000	usd
CY2023Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
awr-20230930_cal.xml	Edgar Link	unprocessable
awr-20230930_def.xml	Edgar Link	unprocessable
awr-20230930_lab.xml	Edgar Link	unprocessable
awr-20230930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0001628280-23-037070-index-headers.html	Edgar Link	pending
R4.htm	Edgar Link	pending
0001628280-23-037070-index.html	Edgar Link	pending
0001628280-23-037070.txt	Edgar Link	pending
0001628280-23-037070-xbrl.zip	Edgar Link	pending
awr-20230930.htm	Edgar Link	pending
awr-20230930.xsd	Edgar Link	pending
awr-20230930xex311.htm	Edgar Link	pending
awr-20230930xex3111.htm	Edgar Link	pending
awr-20230930xex312.htm	Edgar Link	pending
awr-20230930xex3121.htm	Edgar Link	pending
awr-20230930xex321.htm	Edgar Link	pending
awr-20230930xex322.htm	Edgar Link	pending
exhibit108-amendedandexe.htm	Edgar Link	pending
exhibit108-amendedandexe001.jpg	Edgar Link	pending
exhibit108-amendedandexe002.jpg	Edgar Link	pending
exhibit108-amendedandexe003.jpg	Edgar Link	pending
exhibit108-amendedandexe004.jpg	Edgar Link	pending
exhibit108-amendedandexe005.jpg	Edgar Link	pending
exhibit108-amendedandexe006.jpg	Edgar Link	pending
exhibit108-amendedandexe007.jpg	Edgar Link	pending
exhibit108-amendedandexe008.jpg	Edgar Link	pending
exhibit108-amendedandexe009.jpg	Edgar Link	pending
exhibit108-amendedandexe010.jpg	Edgar Link	pending
exhibit108-amendedandexe011.jpg	Edgar Link	pending
exhibit108-amendedandexe012.jpg	Edgar Link	pending
exhibit108-amendedandexe013.jpg	Edgar Link	pending
exhibit108-amendedandexe014.jpg	Edgar Link	pending
exhibit108-amendedandexe015.jpg	Edgar Link	pending
exhibit108-amendedandexe016.jpg	Edgar Link	pending
exhibit108-amendedandexe017.jpg	Edgar Link	pending
exhibit108-amendedandexe018.jpg	Edgar Link	pending
exhibit108-amendedandexe019.jpg	Edgar Link	pending
exhibit108-amendedandexe020.jpg	Edgar Link	pending
exhibit108-amendedandexe021.jpg	Edgar Link	pending
exhibit108-amendedandexe022.jpg	Edgar Link	pending
exhibit108-amendedandexe023.jpg	Edgar Link	pending
exhibit108-amendedandexe024.jpg	Edgar Link	pending
exhibit108-amendedandexe025.jpg	Edgar Link	pending
exhibit108-amendedandexe026.jpg	Edgar Link	pending
exhibit108-amendedandexe027.jpg	Edgar Link	pending
exhibit108-amendedandexe028.jpg	Edgar Link	pending
exhibit108-amendedandexe029.jpg	Edgar Link	pending
exhibit108-amendedandexe030.jpg	Edgar Link	pending
exhibit108-amendedandexe031.jpg	Edgar Link	pending
awr-20230930_htm.xml	Edgar Link	completed
exhibit108-amendedandexe032.jpg	Edgar Link	pending
exhibit108-amendedandexe033.jpg	Edgar Link	pending
exhibit108-amendedandexe034.jpg	Edgar Link	pending
exhibit108-amendedandexe035.jpg	Edgar Link	pending
exhibit108-amendedandexe036.jpg	Edgar Link	pending
exhibit108-amendedandexe037.jpg	Edgar Link	pending
exhibit108-amendedandexe038.jpg	Edgar Link	pending
exhibit108-amendedandexe039.jpg	Edgar Link	pending
exhibit108-amendedandexe040.jpg	Edgar Link	pending
exhibit108-amendedandexe041.jpg	Edgar Link	pending
exhibit108-amendedandexe042.jpg	Edgar Link	pending
exhibit108-amendedandexe043.jpg	Edgar Link	pending
exhibit108-amendedandexe044.jpg	Edgar Link	pending
exhibit108-amendedandexe045.jpg	Edgar Link	pending
exhibit108-amendedandexe046.jpg	Edgar Link	pending
exhibit108-amendedandexe047.jpg	Edgar Link	pending
exhibit108-amendedandexe048.jpg	Edgar Link	pending
exhibit108-amendedandexe049.jpg	Edgar Link	pending
exhibit108-amendedandexe050.jpg	Edgar Link	pending
exhibit108-amendedandexe051.jpg	Edgar Link	pending
exhibit108-amendedandexe052.jpg	Edgar Link	pending
exhibit108-amendedandexe053.jpg	Edgar Link	pending
exhibit108-amendedandexe054.jpg	Edgar Link	pending
exhibit108-amendedandexe055.jpg	Edgar Link	pending
exhibit108-amendedandexe056.jpg	Edgar Link	pending
exhibit108-amendedandexe057.jpg	Edgar Link	pending
exhibit108-amendedandexe058.jpg	Edgar Link	pending
exhibit108-amendedandexe059.jpg	Edgar Link	pending
exhibit108-amendedandexe060.jpg	Edgar Link	pending
exhibit108-amendedandexe061.jpg	Edgar Link	pending
exhibit108-amendedandexe062.jpg	Edgar Link	pending
exhibit108-amendedandexe063.jpg	Edgar Link	pending
exhibit108-amendedandexe064.jpg	Edgar Link	pending
exhibit108-amendedandexe065.jpg	Edgar Link	pending
exhibit108-amendedandexe066.jpg	Edgar Link	pending
exhibit108-amendedandexe067.jpg	Edgar Link	pending
exhibit108-amendedandexe068.jpg	Edgar Link	pending
exhibit108-amendedandexe069.jpg	Edgar Link	pending
exhibit108-amendedandexe070.jpg	Edgar Link	pending
exhibit108-amendedandexe071.jpg	Edgar Link	pending
exhibit108-amendedandexe072.jpg	Edgar Link	pending
exhibit108-amendedandexe073.jpg	Edgar Link	pending
exhibit108-amendedandexe074.jpg	Edgar Link	pending
exhibit108-amendedandexe075.jpg	Edgar Link	pending
exhibit108-amendedandexe076.jpg	Edgar Link	pending
exhibit108-amendedandexe077.jpg	Edgar Link	pending
exhibit108-amendedandexe078.jpg	Edgar Link	pending
exhibit108-amendedandexe079.jpg	Edgar Link	pending
exhibit108-amendedandexe080.jpg	Edgar Link	pending
exhibit108-amendedandexe081.jpg	Edgar Link	pending
exhibit108-amendedandexe082.jpg	Edgar Link	pending
exhibit108-amendedandexe083.jpg	Edgar Link	pending
exhibit108-amendedandexe084.jpg	Edgar Link	pending
exhibit108-amendedandexe085.jpg	Edgar Link	pending
exhibit108-amendedandexe086.jpg	Edgar Link	pending
exhibit108-amendedandexe087.jpg	Edgar Link	pending
exhibit108-amendedandexe088.jpg	Edgar Link	pending
exhibit108-amendedandexe089.jpg	Edgar Link	pending
exhibit108-amendedandexe090.jpg	Edgar Link	pending
exhibit108-amendedandexe091.jpg	Edgar Link	pending
exhibit108-amendedandexe092.jpg	Edgar Link	pending
exhibit108-amendedandexe093.jpg	Edgar Link	pending
exhibit108-amendedandexe094.jpg	Edgar Link	pending
exhibit108-amendedandexe095.jpg	Edgar Link	pending
exhibit108-amendedandexe096.jpg	Edgar Link	pending
exhibit108-amendedandexe097.jpg	Edgar Link	pending
exhibit108-amendedandexe098.jpg	Edgar Link	pending
exhibit108-amendedandexe099.jpg	Edgar Link	pending
exhibit108-amendedandexe100.jpg	Edgar Link	pending
exhibit108-amendedandexe101.jpg	Edgar Link	pending
exhibit108-amendedandexe102.jpg	Edgar Link	pending
exhibit108-amendedandexe103.jpg	Edgar Link	pending
exhibit108-amendedandexe104.jpg	Edgar Link	pending
exhibit108-amendedandexe105.jpg	Edgar Link	pending
exhibit108-amendedandexe106.jpg	Edgar Link	pending
exhibit108-amendedandexe107.jpg	Edgar Link	pending
exhibit108-amendedandexe108.jpg	Edgar Link	pending
exhibit108-amendedandexe109.jpg	Edgar Link	pending
exhibit108-amendedandexe110.jpg	Edgar Link	pending
exhibit108-amendedandexe111.jpg	Edgar Link	pending
exhibit108-amendedandexe112.jpg	Edgar Link	pending
exhibit108-amendedandexe113.jpg	Edgar Link	pending
exhibit108-amendedandexe114.jpg	Edgar Link	pending
exhibit108-amendedandexe115.jpg	Edgar Link	pending
exhibit108-amendedandexe116.jpg	Edgar Link	pending
exhibit108-amendedandexe117.jpg	Edgar Link	pending
exhibit108-amendedandexe118.jpg	Edgar Link	pending
exhibit108-amendedandexe119.jpg	Edgar Link	pending
exhibit108-amendedandexe120.jpg	Edgar Link	pending
exhibit108-amendedandexe121.jpg	Edgar Link	pending
exhibit108-amendedandexe122.jpg	Edgar Link	pending
exhibit108-amendedandexe123.jpg	Edgar Link	pending
exhibit108-amendedandexe124.jpg	Edgar Link	pending
exhibit108-amendedandexe125.jpg	Edgar Link	pending
exhibit108-amendedandexe126.jpg	Edgar Link	pending
exhibit108-amendedandexe127.jpg	Edgar Link	pending
exhibit108-amendedandexe128.jpg	Edgar Link	pending
exhibit108-amendedandexe129.jpg	Edgar Link	pending
exhibit108-amendedandexe130.jpg	Edgar Link	pending
exhibit108-amendedandexe131.jpg	Edgar Link	pending
exhibit108-amendedandexe132.jpg	Edgar Link	pending
exhibit108-amendedandexe133.jpg	Edgar Link	pending
exhibit108-amendedandexe134.jpg	Edgar Link	pending
exhibit108-amendedandexe135.jpg	Edgar Link	pending
exhibit108-amendedandexe136.jpg	Edgar Link	pending
exhibit108-amendedandexe137.jpg	Edgar Link	pending
exhibit108-amendedandexe138.jpg	Edgar Link	pending
exhibit108-amendedandexe139.jpg	Edgar Link	pending
exhibit108-amendedandexe140.jpg	Edgar Link	pending
exhibit108-amendedandexe141.jpg	Edgar Link	pending
exhibit108-amendedandexe142.jpg	Edgar Link	pending
exhibit108-amendedandexe143.jpg	Edgar Link	pending
exhibit108-amendedandexe144.jpg	Edgar Link	pending
exhibit108-amendedandexe145.jpg	Edgar Link	pending
exhibit108-amendedandexe146.jpg	Edgar Link	pending
exhibit108-amendedandexe147.jpg	Edgar Link	pending
exhibit108-amendedandexe148.jpg	Edgar Link	pending
exhibit108-amendedandexe149.jpg	Edgar Link	pending
exhibit108-amendedandexe150.jpg	Edgar Link	pending
exhibit108-amendedandexe151.jpg	Edgar Link	pending
exhibit108-amendedandexe152.jpg	Edgar Link	pending
exhibit108-amendedandexe153.jpg	Edgar Link	pending
exhibit108-amendedandexe154.jpg	Edgar Link	pending
exhibit108-amendedandexe155.jpg	Edgar Link	pending
exhibit108-amendedandexe156.jpg	Edgar Link	pending
exhibit108-amendedandexe157.jpg	Edgar Link	pending
exhibit108-amendedandexe158.jpg	Edgar Link	pending
exhibit108-amendedandexe159.jpg	Edgar Link	pending
exhibit108-amendedandexe160.jpg	Edgar Link	pending
exhibit108-amendedandexe161.jpg	Edgar Link	pending
exhibit108-amendedandexe162.jpg	Edgar Link	pending
exhibit108-amendedandexe163.jpg	Edgar Link	pending
exhibit108-amendedandexe164.jpg	Edgar Link	pending
exhibit108-amendedandexe165.jpg	Edgar Link	pending
exhibit108-amendedandexe166.jpg	Edgar Link	pending
exhibit108-amendedandexe167.jpg	Edgar Link	pending
exhibit108-amendedandexe168.jpg	Edgar Link	pending
exhibit108-amendedandexe169.jpg	Edgar Link	pending
exhibit108-amendedandexe170.jpg	Edgar Link	pending
exhibit108-amendedandexe171.jpg	Edgar Link	pending
exhibit108-amendedandexe172.jpg	Edgar Link	pending
exhibit108-amendedandexe173.jpg	Edgar Link	pending
exhibit108-amendedandexe174.jpg	Edgar Link	pending
exhibit108-amendedandexe175.jpg	Edgar Link	pending
exhibit108-amendedandexe176.jpg	Edgar Link	pending
exhibit108-amendedandexe177.jpg	Edgar Link	pending
exhibit108-amendedandexe178.jpg	Edgar Link	pending
exhibit108-amendedandexe179.jpg	Edgar Link	pending
exhibit108-amendedandexe180.jpg	Edgar Link	pending
exhibit108-amendedandexe181.jpg	Edgar Link	pending
exhibit108-amendedandexe182.jpg	Edgar Link	pending
exhibit108-amendedandexe183.jpg	Edgar Link	pending
exhibit108-amendedandexe184.jpg	Edgar Link	pending
exhibit108-amendedandexe185.jpg	Edgar Link	pending
exhibit108-amendedandexe186.jpg	Edgar Link	pending
exhibit109-policyregarding.htm	Edgar Link	pending
exhibit31-awrbylawsxamende.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AWR
AMERICAN STATES WATER CO Stock $awr

2023 Q4 Form 10-Q Financial Statement

#000162828023037070 Filed on November 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AWR AMERICAN STATES WATER CO Stock $awr

2023 Q4 Form 10-Q Financial Statement

#000162828023037070 Filed on November 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AWR
AMERICAN STATES WATER CO Stock $awr